Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer, Solid tumors, Non-Small-Cell Lung Carcinoma, Letrozole, Fulvestrant, Palbociclib
Lead Scientist at UCSF
- Hope Rugo
Dr. Hope Rugo is a medical oncologist and hematologist specializing in breast cancer research and treatment. A Clinical Professor of Medicine, Dr. Rugo joined the Breast Care Center in 1999 after a decade of experience at UCSF in malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer.
- accepting new patients at some sites,
but this study is not currently recruiting here
- Start Date
- Completion Date
- To obtain contact information for a study center near you, click here.
- Phase 1 research study
- Study Type
- Expecting 108 study participants
- Last Updated